Social Justice

Justice, Equity, Diversity, & Inclusion

The Diversity, Equity, and Inclusion (DEI) Committee was formed to support the Board of Psychedelic Medicine and Therapies (BPMT) in bringing its values of justice, equity, diversity, and inclusion (JEDI) into organizational operations at every level. We understand that a commitment to these values requires that we transform organizational structures and processes so that equity is actualized in practice, not in principle alone. We recognize that organizations and the work that they produce are stronger and more successful when diverse perspectives are incorporated, and that centering marginalized voices is essential to overcome structural inequity.

Mission of the DEI Committee

Our mission is to serve as a hub at the center of the Board of Psychedelic Medicine and Therapies (BPMT), working closely with the Board of directors and executive team on all matters to ensure the integrity of the organizations processes and deliverables, integrated with justice, equity, diversity, and inclusion (JEDI) principles at the core.

People

DEI Committee

Diana Quinn, ND

Diana Quinn, ND

Co-Chair, Board Member

Diana Quinn, ND, is a queer Chicana and licensed naturopathic doctor with over fifteen years of clinical experience in integrative mental health with a focus on trauma, somatics and mind-body medicine. Her work is grounded in healing justice, a framework that aims to intervene on generational trauma and bring collective practices to transform the consequences of oppression. She is dedicated to building equity, accessibility and structural competency in the field of psychedelics. She is a co-founder of the Psychedelic Liberation Collective, offering community care, anti-racism resources, and monthly integration circles for Black, Indigenous and people of color and the 2SLGBTQIA+ community. Dr. Quinn has recently completed training in the California Institute for Integral Studies Psychedelic-Assisted Therapies and Research program and is a member of Chacruna’s Racial Equity and Access Committee. She sits on boards and advisory committees for multiple organizations and initiatives focused on justice, equity, diversity and access (JEDI).

Sara Reed, MS, LMFT

Sara Reed, MS, LMFT

Co-Chair, Board Member

Sara Reed, MS, LMFT, is an empathic leader, mental health futurist, and clinical researcher, Sara examines the ways culture informs the way we diagnose and treat mental illness. She is a Licensed Marriage and Family Therapist and the CEO of Mind's iHealth Solutions, a digital health company that provides evidence based and culturally responsible mental health services for underserved groups. She supervises and trains clinicians in providing culturally responsible mental health treatment. Sara's prior research work includes participating as a Study Therapist on the Psilocybin-Assisted Therapy research study for Major Depression at Yale University. Before joining the research team at Yale, Sara was a SubInvestigator and Study Coordinator for the Multidisciplinary Association for Psychedelic Studies (MAPS) Phase 2 MDMA Clinical Study of Posttraumatic Stress Disorder (PTSD). Sara is also an Advisor for Journey Colab and a former member of Chacruna's Racial Equity and Access Committee.

Joseph La Torre, MS

Joseph La Torre, MS

Committee Member

Joseph La Torre, MS, is a clinical psychology doctoral student at the University of Ottawa focusing on phenomenology of psychedelic mystical states, Indigenous modalities of healing, and culturally-informed approaches to psychopathology assessment and treatment. He completed his Masters in Buddhist Studies at Harvard University where he was a Dean’s Fellow, and he is an alum of the U.S.-Nepal Fulbright Program. He has taught graduate and undergraduate students as a co-instructor for Psychedelics: An Interdisciplinary Survey of Psychedelic Studies, part of the microprogram and emerging Master’s program in Psychedelics, Spirituality, and Consciousness at uOttawa. His dissertation research explores the possibility of psychedelic-assisted psychotherapy for individuals with psychotic symptoms. In addition to English, he is fluent in Mandarin Chinese and German, and also speaks Italian and Japanese.

Mailae Halstead, MS, LPC

Mailae Halstead, MS, LPC

Committee Member

Mailae Halstead, MS, LPC, is a licensed, Nationally Certified Counselor currently based in Tolland, Connecticut. While much of her work is spent treating PTSD and OCD using empirically-supported treatments, she also conducts ketamine-assisted therapy (KAP). She is passionate about practicing psychedelic-assisted psychotherapy in a way that centers cultural humility and empowerment. Mailae is a treatment advisor for the Connecticut Expanded Access site sponsored by the Multidisciplinary Association of Psychedelics Public Benefit Corporation (MAPS PBC) using MDMA-assisted psychotherapy for the treatment of PTSD. She is also a teaching assistant, lecturer, and group facilitator for the Integrative Psychiatry Institute’s Psychedelic-Assisted Psychotherapy training program. Mailae regularly provides ketamine-assisted psychotherapy for the treatment of depression, PTSD, and anxiety. She aspires to contribute to a future with equitable and de-stigmatized access to psychedelic healing.

Rebecca Keel, MSW

Rebecca Keel, MSW

Committee Member

Rebecca Keel, MSW, focuses their work on intersectional strategies to undo harmful policies that impact the lives of Black folks and all marginalized people of color, the poor-working class, queer and trans communities, people who use drugs, youth, and folks with disabilities. They have over 10 years experience community organizing and transformative electoral work within marginalized groups. Rebecca also holds a Masters in Clinical Social Work and currently serves as Regional Membership Manager with Southerners On New Ground (SONG). They have served on numerous DEI boards and committees, operate their own DEI consultancy, and has received various accolades for their commitment to justice and equity. Rebecca is from Richmond, Virginia, and currently lives in New Orleans, Louisiana.

Keeno Ahmed-Jones

Keeno Ahmed-Jones, MA

Committee Member

Keeno Ahmed-Jones, MA, is an empathic educator and big-picture thinker who has led policy, advocacy, communications and government relations strategies to provide equitable access for historically underserved and marginalized populations. As a Regents Research Fund Fellow in New York, Keeno spearheaded multi-year initiatives that resulted in statewide education policy and regulatory changes that helped close the opportunity gap for out-of-school youth and adults without a high school diploma. As co-lead of the Diversity Committee at MAPS Canada, Keeno's vocal advocacy against discriminatory practices in the psychedelic research domain and efforts to implement initiatives addressing race-based health disparities led to an overhaul of the board and the adoption of over 90% of her recommendations. Keeno’s work as a diversity, equity and inclusion consultant combines a lifelong commitment to human rights and social justice with expertise in organizational development, program evaluation and community engagement to advise nonprofits and the private sector on the meaningful implementation of culturally competent practices and how to advance DE&I values with integrity and care. A board member of Alma Institute, an Oregon-based psychedelic training and mentorship program fiscally sponsored by MAPS, and advisor to various organizations in the fields of mental health and substance use, Keeno received her Masters in Sociology and Education Policy from Teachers College at Columbia University.

Resources

Learn More

Organizations Supporting Equity

Psychedelic Liberation Collective

The PLC is a group of queer, BI&POC-led people working collectively to create spaces for healing and transformation for our communities. Our goal is to facilitate decentralized spaces for community support, and provide information about psychedelics in an approach grounded in social justice. We recognize that some of the obstacles for our communities in accessing the benefits of psychedelics are 1) insufficient number of BI&POC providers/guides, 2) lack of cultural humility in white providers/guides, 3) microaggressions and overt racism in wider psychedelic spaces, and 4) lack of information about or access to these substances in our communities. These obstacles are situated inside the larger systemic and structural barriers which include ongoing threat to physical safety; the criminalization of Black and brown people in the War on Drugs and terrorism by the carceral state; the disparity of generational wealth for Black and brown people resulting from racial capitalism and leading to barriers in access to material resources, educational opportunities, and healing modalities; and more.

Chacruna Institute for Psychedelic Plant Medicines

Chacruna provides public education and cultural understanding about psychedelic plant medicines and promote a bridge between the ceremonial use of sacred plants and psychedelic science. We envision a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal and health care systems.

The Ancestor Project

The Ancestor Project integrates ancestral Sacred Earth Medicine wisdom into the modern journeyers’ experience to reduce harm and expand consciousness. We believe that Sacred Earth Medicine is key in liberating all oppressed peoples. We facilitate online and in-person opportunities for learning that support radical self-transformation in the name of collective liberation.

Recommended Reading

Belser, A. (2019, 17 October). 10 Calls to Action: Toward an LGBTQ-Affirmative Psychedelic Therapy: Combating Heteronormative Paradigms in Psychedelic Science. Chacruna Institute.

Okun, T. (2021). White Supremacy Culture - Still Here. DismantlingRacism.org

Journal Articles

Smith, D. T., Faber, S. C., Buchanan, N. T., Foster, D. & Green, L. (2022). The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of Its Provision. Frontiers in Psychiatry 12, 774736. doi: 10.3389/fpsyt.2021.774736

Pilecki, B., Luoma, J. B., Bathje, G. J., et al. (2021). Ethical and legal issues in psychedelic harm reduction and integration therapy. Harm Reduction Journal (18) 40.

Ching, T. H. W. (2020). Intersectional insights from an MDMA-assisted psychotherapy training trial: An open letter to racial/ethnic and sexual/gender minorities. Journal of Psychedelic Studies, 4(1), 61-68.

Fotiou, E. (2020). The role of Indigenous knowledges in psychedelic science. Journal of Psychedelic Studies, 4(1), 16-23.

Fogg, C., Michaels, T. I., de la Salle, S., Jahn, Z. W., & Williams, M. T. (2021). Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic medicine. Experimental and Clinical Psychopharmacology, 29(5), 539–554. doi: 10.1037/pha0000490

Halstead, M., Reed, S., Krause, R., & Williams, M. T. (2021). Ketamine-assisted psychotherapy for PTSD related to experiences of racial discrimination. Clinical Case Studies, 20(4), 310-330. doi: 10.1177/1534650121990894

Williams, M. T., Reed, S., & George, J. (2020). Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists. Journal of Psychedelic Studies, 4(3), 125-138.

Williams, M. T., Reed, S., & Aggarwal, R. (2020). Culturally-informed research design issues in a study for MDMA-assisted psychotherapy for posttraumatic stress disorder. Journal of Psychedelic Studies, 4(1), 40–50. doi: 10.1556/2054.2019.016

George, J. R., Michaels, T. I., Sevelius, J., & Williams, M. T. (2020). The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion. Journal of Psychedelic Studies, 4(1), 4-15. doi: 10.1556/2054.2019.015

Williams, M. T., & Leins, C. (2016). Race-based trauma: The challenge and promise of MDMA-assisted psychotherapy. Multidisciplinary Association for Psychedelic Studies (MAPS) Bulletin, 26(1), 32-37.